Fritextsökning
Innehållstyper
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Studie: Ny typ av cellterapi kan läka skador på hjärta efter infarkt
I en ny studie har forskare från bland annat Karolinska institutet, Astra Zeneca och Technical University of Munich identifierat en ny typ av cellterapi som har...
-
Ny chef på Bactiguard
I augusti tillträder Gabriella Björknert Caracciolo som ny CFO samt vice vd på Bactiguard.
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Pengaregn över forskare
Långvariga infektioner, smärta och mitokondriernas genuttryck är några av de ämnen som delar på pengarna när Knut och Alice Wallenbergs Stiftelse delar ut 752 m...
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Astra i ännu ett avtal
Tecknar ännu ett licensavtal och visar upp negativa resultat från klinisk studie på malignt mesoteliom.
-
"Individer som har modet att engagera sig måste belönas"
Sara Gunnerås, director business and finance, SwedenBio kommenterar det femte förslaget om Skärp målsättningen för deltagande i EU:s ramprogram.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
BMS satsar på mer samarbete – inrättar ny funktion
Mer innovativa samarbeten och partnerskap är framtiden inom life science-sektorn, och för att främja det inrättar nu Bristol Myers Squibb, BMS, en helt ny funkt...
-
Hon tar plats på Bactiguard
Petra Kaur Ljungman tillträder den nyinrättade rollen som global marknads- och kommunikationschef.
-
VTT in brief
VTT is a broad science cluster with research within applied materials, chemical and biochemical processes, energy, industrial systems management, information an...
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Hallå där Korbinian Löbmann
Korbinian Löbmann kommer att moderera Life Science Swedens kommande event New updates in Drug Formulation & Bioavailability den 1 september.
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Partnering offer for scientists and medics
For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I
BREAKING